Scientists have found a promising new way to deliver targeted treatments to diseased parts of the brain, and it could be a ...

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...

A new study reveals that chronic stress activates immune cells that travel to the brain, amplify inflammation, and heighten fear responses.

A new study published in Nature by researchers at Harvard Medical School has found that psychedelic compounds can reduce ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Mass General Brigham researchers found that immune cells influence brain communication in response to stress, driving fear ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...